Brief: Newamsterdam Pharma Company NV Announces Appointment Of David Topper As Chief Financial Officer
Dec 19 (Reuters) - NewAmsterdam Pharma Company NV
NAMS.O :
* NEWAMSTERDAM ANNOUNCES APPOINTMENT OF DAVID TOPPER AS
CHIEF
FINANCIAL OFFICER
* NEWAMSTERDAM PHARMA COMPANY NV - ANNOUNCED APPOINTMENT OF
DAVID
TOPPER AS CHIEF FINANCIAL OFFICER ("CFO"), EFFECTIVE JANUARY 1,
2023
* NEWAMSTERDAM PHARMA COMPANY NV - DAVID TOPPER SUCCEEDS
LOUISE
KOOIJ, WHO WILL TRANSITION TO ROLE OF CHIEF ACCOUNTING OFFICER
Source text for Eikon: ID:nGNX2np0ct
Further company coverage: NAMS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)